Overcoming Supply Chain Challenges

In this exclusive PC Podcast interview, Chip Davis, president and CEO of the Healthcare Distribution Alliance (HDA), a national organization that represents primary pharmaceutical distributors, discusses the benefits of the Distribution Management Conference, and the value it provides for the industry; a three-year check-in since his last chat with Pharmaceutical Commerce, including a look at how the challenges presented to distributors now differ, and how they are being addressed; progress that has been made toward full connectivity since the FDA announced a “stabilization period” to finalize implementation of the DSCSA before November 2024, along with some of the most significant issues for trading partners; some of the root causes of drug shortages, and how distributors are work to mitigate them; and key initiatives and plans that the HDA is focused on for the second half of 2024, and how these will shape the future of the pharmaceutical supply chain.